跳至主要内容
临床试验/NCT03160781
NCT03160781已完成2 期

Pilot Study to Evaluate Combination of Intraosseous With Intra-articular Infiltrations of Plasma Rich in Growth Factors (PRGF®-Endoret®) in the Treatment of Knee Osteoarthritis.

Unidad de Cirugía Artroscópica0 个研究点目标入组 19 人开始时间: 2014年1月28日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
19
主要终点
Pain according to KOOS scale at 6 months after treatment

研究概览

简要总结

The aim of this study was to assess a novel approach to treating severe knee osteoarthritis by targeting synovialmembrane, superficial articular cartilage, synovial fluid, and subchondral bone by combining intra-articular injections and intraosseous infiltrations of platelet rich plasma.This study explored a new strategy consisting of intraosseous infiltrations of platelet rich plasma into the subchondral bone in combination with the conventional intra-articular injection in order to tackle several knee joint tissues simultaneously.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 77 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of both sexes aged 40 to 77 years.
  • Predominant internal tibiofemoral knee osteoarthritis.
  • Joint pain above 2.5 VAS points.
  • Radiographic severity degrees 3 and 4 according to Ahlbäck scale.
  • Values of body mass index between 20 and
  • Possibility for observation during the follow-up period.

排除标准

  • Bilateral knee osteoarthritis which requires infiltration in both knees.
  • Values of body mass index >
  • Polyarticular disease diagnosed.
  • Severe mechanical deformity (diaphyseal varus of 4∘ and valgus of 16∘).
  • Arthroscopy in the last year prior to treatment.
  • Intra-articular infiltration of hyaluronic acid in the past 6 months.
  • Systemic autoimmune rheumatic disease (connective tissue diseases and systemic necrotizing vasculitis).
  • Poorly controlled diabetes mellitus (glycosylated hemoglobin above 9%).
  • Blood disorders (thrombopathy, thrombocytopenia, and anemia with Hb < 9).
  • Undergoing immunosuppressive therapy and/or warfarin.
  • Treatment with corticosteroids during the 6 months prior to inclusion in the study.

结局指标

主要结局

Pain according to KOOS scale at 6 months after treatment

时间窗: 6 months

Pain according to KOOS scale

次要结局

  • Symptoms according to KOOS scale at 6 months after treatment(6 months)
  • Function according to KOOS scale at 6 months after treatment(6 months)
  • Sport Activity according to KOOS scale at 6 months after treatment(6 months)
  • QoL according to KOOS scale at 6 months after treatment(6 months)

研究者

发起方
Unidad de Cirugía Artroscópica
申办方类型
Other
责任方
Sponsor

相似试验